SCHEMBL30288589

SCHEMBL30288589

CNC(=O)[C@H](Cc1cccc(Br)c1)NC(=O)c1cc(-c2ccc(C)cc2)n(Cc2ccccc2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 1/20 0.54
▸ CTSB P07858 6/20 0.49
▸ CTSS P25774 6/20 0.49
▸ CTSL P07711 5/20 0.49
▸ CTSK P43235 5/20 0.49
▸ MGLL Q99685 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ P2RY14 Q15391 2/20 0.43
▸ HDAC6 Q9UBN7 2/20 0.43
▸ HDAC3 O15379 1/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC7 Q8WUI4 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ HDAC10 Q969S8 1/20 0.43
▸ HDAC11 Q96DB2 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ HDAC9 Q9UKV0 1/20 0.43
▸ HDAC5 Q9UQL6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30288612 0.95 MALT1 (0.56) MALT1CTSBCTSSCTSLCTSK
SCHEMBL26307120 0.93 MALT1 (0.49) MALT1CTSBCTSSCTSLCTSK
SCHEMBL30288624 0.93 MALT1 (0.49) MALT1CTSBCTSSCTSLCTSK
SCHEMBL30288595 0.93 MALT1 (0.49) MALT1CTSBCTSSCTSLCTSK
SCHEMBL30288608 0.93 MALT1 (0.53) MALT1CTSBCTSSCTSLCTSK
SCHEMBL30288584 0.91 MALT1 (0.52) MALT1CTSBCTSSCTSLCTSK
SCHEMBL30288649 0.89 MALT1 (0.48) MALT1CTSBCTSSCTSLCTSK
SCHEMBL25412557 0.89 MALT1 (0.48) MALT1CTSBCTSSCTSLCTSK
SCHEMBL25412556 0.89 MALT1 (0.48) MALT1CTSBCTSSCTSLCTSK
SCHEMBL30288593 0.87 SLC16A3 (0.48) MALT1CTSBCTSSCTSLCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115894373-A N-substituted benzylpyrazole derivatives as beta 2 Use of allosteric modulators, antagonists and agonists of the adrenergic receptor 常州大学 2023-04-04 — — CN disclosed
Send feedback